Other OTC - Delayed Quote • USD
Khiron Life Sciences Corp. (KHRNF)
As of April 22 at 11:32 AM EDT. Market Open.
Key Executives
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Alvaro Francisco Torres | Co-Founder, CEO & Director | 199.09k | -- | 1979 |
Ms. Franziska Katterbach | President of Khiron Europe | 281.3k | -- | -- |
Mr. Swapan Kakumanu ACA, ACWA, CGA | Corporate Secretary | 43.76k | -- | 1970 |
Mr. Michael John O'Connor MA | Chief Financial Officer | -- | -- | 1967 |
Mr. Manuel Buendia | Vice President of Operations | -- | -- | -- |
Mr. Marco Algorta | Country Manager of Uruguay | -- | -- | -- |
Khiron Life Sciences Corp.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.
Corporate Governance
Khiron Life Sciences Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- Jun 22, 2022D: Additional FormsSee Full Filing
Upcoming Events
Upcoming Events Information Not Available
Related Tickers
TGIFF 1933 Industries Inc.
0.0116
+2.65%
AGXRW Agile Therapeutics, Inc.
0.0001
0.00%
THCT THC Therapeutics, Inc.
0.0032
0.00%
LTTSF Lotus Ventures Inc.
0.0163
0.00%
CHAL.CN Chalice Brands Ltd.
0.2250
0.00%
PCLOF PharmaCielo Ltd.
0.1182
+3.78%
AVCNF Avicanna Inc.
0.2631
-6.24%
LOWLF Lowell Farms Inc.
0.0628
-21.49%
ITHUF iAnthus Capital Holdings, Inc.
0.0177
-5.85%
TLLTF TILT Holdings Inc.
0.0324
+15.71%